SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR Annual Meeting

/in ,

SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR Annual Meeting

SuperGen’s DNA Methyltransferase Inhibitor, S-110, Improves In Vivo Efficacy Profile of Decitabine

/in ,

SuperGen’s DNA Methyltransferase Inhibitor, S-110, Improves In Vivo Efficacy Profile of Decitabine

Astex Receives IND Approval for its Small Molecule HSP90 Inhibitor AT13387; Astex Announces Extension of Drug Discovery Alliance

/in ,

Astex Receives IND Approval for its Small Molecule HSP90 Inhibitor AT13387; Astex Announces Extension of Drug Discovery Alliance

SuperGen’s Novel Hypomethylating Agent Highlighted at American Society of Hematology Annual Meeting

/in ,

SuperGen’s Novel Hypomethylating Agent Highlighted at American Society of Hematology Annual Meeting

Data Indicate That SuperGen’s Lead JAK2 Kinase Inhibitors Prevent Cancer Cell Proliferation in Non-clinical Models

/in ,

Data Indicate That SuperGen’s Lead JAK2 Kinase Inhibitors Prevent Cancer Cell Proliferation in Non-clinical Models

SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the American Society of Hematology’s 49th Annual Meeting

/in ,

SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the American Society of Hematology’s 49th Annual Meeting